Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by Boomskidon Feb 15, 2023 6:28pm
80 Views
Post# 35288656

RE:RE:RE:RE:Another Midatech Deal Coming for Bioasis??

RE:RE:RE:RE:Another Midatech Deal Coming for Bioasis??As I posted, ROSIE2023, I agree with you that the deal has been terminated but if both sides suddenly said, "Well, wait a minute...!"

There is nothing stopping Midatech, Bioasis, Ladenburg Thalmann and the placees from going at it all over again, figuring that Midatech and Bioasis shareholders, who have had a recent near-death experience, might well give up and go for the deal.

xB3, if it works as hoped, will be a big win for whoever has it. I believe they may go for it again.

Rathjen in the deal termination PR expressed her disappointment that Midatech shareholders voted the deal down. And then Bioasis shareholders voted for the deal.

She's shameless. She'll do it again and this time it will go through.

jd
<< Previous
Bullboard Posts
Next >>